NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE CAP
Steris PLC STE
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY9 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$5.9B
▲ 8.7% vs FY2024
Dividend streak
9 yrs
Raised every year since 2017
EPS · FY25
$7.93
Dividend / sh · FY25
$2.46
Payout · FY25
31%
ROE · FY25
11.3%
Net margin · FY25
13.2%
Dividend coverage
3.2×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.9B
Revenue, FY2025 · full 10-year series below
Revenue
Net income
13 cents of every revenue dollar became profit this year.
Per share
USD 7.93
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 3.2 times — the rest stayed in the company.
Profitability
11.3%
Return on equity, FY2025
ROE
Operating margin18.6%
Net margin13.2%
Return on assets7.5%
Each USD of equity produced 11 cents of profit this year.
Returned to shareholders
USD 444.4M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 241.8M
Net buybacksUSD 202.6M
Share of profit56.8%
Consecutive raises9 years
USD 241.8M in dividends and USD 202.6M in buybacks — 57% of the year's profit went back to shareholders.
Growth
+13.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+9.4%
+13.8%
Net income
+94.1%
+14.5%
EPS, diluted
+95.0%
+11.4%
Dividend / share
+10.2%
+9.4%
Returned to shareholders
−3.2%
+27.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.10B
Shares outstanding, FY2025
Change, 5 years+14.6%
Change, 10 years—
The share count grew 15% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 10.7B
total assets, end of FY2025
Total assetsUSD 10.7B
EquityUSD 7.2B
CashUSD 439.6M
Gross debtUSD 1.9B
Net debtUSD 1.5B
Current ratio2.09×
Net debt stands at 21% of equity.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
5.9
5.5
5.1
4.5
4.2
3.1
3.0
2.8
2.6
2.6
Operating income $B
1.1
0.9
0.8
0.8
0.5
0.5
0.5
0.4
0.4
0.2
EBITDA $B
1.6
1.3
1.4
1.3
1.0
0.8
0.7
0.6
0.6
0.4
Income tax $B
0.3
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Net income $B
0.8
0.6
0.4
0.1
0.2
0.4
0.4
0.3
0.3
0.1
EPS, diluted $
7.93
6.20
3.81
1.07
2.48
4.63
4.76
3.55
3.39
1.28
Dividend / sh $
2.46
2.23
2.03
1.84
1.69
1.57
1.45
1.33
1.21
1.09
Payout %
31
36
53
171
67
34
30
37
35
85
ROE %
11.3
9.5
6.1
1.7
4.7
10.9
12.4
9.5
9.1
·
Shares out B
0.10
0.10
0.10
0.10
0.10
0.09
0.08
0.08
0.08
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
38 of 38
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed